Pharma-Data SA, a member of Rosemont Pharmaceuticals Ltd., is a Contract Research Organisation (CRO) that excels in research and development along with the creation of Value-Added Medicines. The company focuses on hybrid (505b2) products, offering a range of pharmaceutical services. With a strong commitment to innovation, Pharma-Data SA is dedicated to expanding its reach by licensing its products across Europe, the USA, LATAM, the Middle East, and Southeast Asia.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Finished Dosage Forms
– Research and Development of Hybrid Products
– Regulatory Affairs Support
– Clinical Trials Management
– Market Access Strategies

Pharma-Data S.A. continues to advance the pharmaceutical landscape by providing high-quality services and innovative solutions that meet the needs of clients and partners. For more information, please visit pharmadata.gr.